OBI Pharma, Inc.(TW:4174)
NT$60.50+5.50 (+10.00%)
TW:4174
OBI Pharma, Inc. financials statements
NT$60.50
At close:+5.50 (+10.00%)
OBI Pharma, Inc. (4174) Financial Statements
OBI Pharma, Inc. Financial Overview
OBI Pharma, Inc.'s market cap is currently NT$7.23B. The company's EPS TTM is NT$-27.21; its P/E ratio is -2.37; OBI Pharma, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 58.58M | NT$ 62.68M | NT$ 41.55M | NT$ 4.71M | NT$ 18.77M |
| Gross Profit | NT$ -77.53M | NT$ -76.27M | NT$ -73.50M | NT$ -40.14M | NT$ -25.59M |
| Operating Income | NT$ -2.17B | NT$ -2.37B | NT$ -2.09B | NT$ -1.91B | NT$ -1.74B |
| EBITDA | NT$ -1.94B | NT$ -2.26B | NT$ -1.02B | NT$ -1.67B | NT$ -1.52B |
| Net Income | NT$ -2.05B | NT$ -2.31B | NT$ -1.05B | NT$ -1.90B | NT$ -1.72B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 1.19B | NT$ 3.13B | NT$ 2.78B | NT$ 4.77B | NT$ 2.65B |
| Total Assets | NT$ 3.42B | NT$ 5.65B | NT$ 5.60B | NT$ 6.63B | NT$ 4.49B |
| Total Debt | NT$ 515.68M | NT$ 505.17M | NT$ 501.05M | NT$ 247.09M | NT$ 293.03M |
| Net Debt | NT$ -243.65M | NT$ -1.23B | NT$ -398.22M | NT$ -4.49B | NT$ -2.22B |
| Total Liabilities | NT$ 696.13M | NT$ 833.38M | NT$ 650.45M | NT$ 497.57M | NT$ 615.95M |
| Stockholders' Equity | NT$ 1.89B | NT$ 3.81B | NT$ 3.81B | NT$ 4.63B | NT$ 2.72B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -2.07B | NT$ -1.95B | NT$ -1.76B | NT$ -1.92B | NT$ -1.31B |
| Operating Cash Flow | NT$ -2.02B | NT$ -1.83B | NT$ -1.65B | NT$ -1.62B | NT$ -1.06B |
| Investing Cash Flow | NT$ 908.93M | NT$ 483.02M | NT$ -2.80B | NT$ -169.89M | NT$ 82.68M |
| Financing Cash Flow | NT$ 141.63M | NT$ 2.17B | NT$ 607.07M | NT$ 4.01B | NT$ 163.75M |
Currency in TWD

